Abigail C Mancuso1, Sheree L Boulet2, Eyup Duran3, Erika Munch3, Dmitry M Kissin2, Bradley J Van Voorhis3. 1. Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, Iowa. Electronic address: abigail-mancuso@uiowa.edu. 2. Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Abstract
OBJECTIVE: To determine the effect of elective single ET (eSET) on live birth and multiple birth rates by a cycle-level and clinic-level analysis. DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): Patient ages <35 and 35-37 years old. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Clinics were divided into groups based on eSET rate for each age group and aggregate rates of live birth per ET and multiple birth per delivery were calculated. A cycle-level analysis comparing eSET and double ET (DET) live birth and multiple birth rates was also performed, stratified based on total number (2, 3, or 4+) of embryos available, embryo stage, and patient age. RESULT(S): There was a linear decrease in multiple birth rate with increasing eSET rate and no significant difference in clinic-level live birth rates for each age group. Cycle-level analysis found slightly higher live birth rates with double ET, but this was mainly observed in women aged 35-37 years or with four or more embryos available for transfer, and confirmed the marked reduction in multiple births with eSET. CONCLUSION(S): Our study showed a marked and linear reduction in multiple birth rates, and important, little to no effect on clinic-level live birth rates with increasing rates of eSET supporting the growing evidence that eSET is effective in decreasing the high multiple birth rates associated with IVF and suggests that eSET should be used more frequently than is currently practiced. Published by Elsevier Inc.
OBJECTIVE: To determine the effect of elective single ET (eSET) on live birth and multiple birth rates by a cycle-level and clinic-level analysis. DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): Patient ages <35 and 35-37 years old. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Clinics were divided into groups based on eSET rate for each age group and aggregate rates of live birth per ET and multiple birth per delivery were calculated. A cycle-level analysis comparing eSET and double ET (DET) live birth and multiple birth rates was also performed, stratified based on total number (2, 3, or 4+) of embryos available, embryo stage, and patient age. RESULT(S): There was a linear decrease in multiple birth rate with increasing eSET rate and no significant difference in clinic-level live birth rates for each age group. Cycle-level analysis found slightly higher live birth rates with double ET, but this was mainly observed in women aged 35-37 years or with four or more embryos available for transfer, and confirmed the marked reduction in multiple births with eSET. CONCLUSION(S): Our study showed a marked and linear reduction in multiple birth rates, and important, little to no effect on clinic-level live birth rates with increasing rates of eSET supporting the growing evidence that eSET is effective in decreasing the high multiple birth rates associated with IVF and suggests that eSET should be used more frequently than is currently practiced. Published by Elsevier Inc.
Entities:
Keywords:
Elective single embryo transfer; IVF; live birth rate; multiple birth rate
Authors: Pedro Aa Monteleone; Paula Gmf Petersen; Pedro Fm Peregrino; Juliana Miorin; Alecsandra P Gomes; Mariana G Fujii; Hamilton de Martin; Tatiana Cs Bonetti; Sergio P Gonçalves Journal: JBRA Assist Reprod Date: 2019-08-22
Authors: Benjamin J Peipert; Melissa N Montoya; Bronwyn S Bedrick; David B Seifer; Tarun Jain Journal: Reprod Biol Endocrinol Date: 2022-08-04 Impact factor: 4.982
Authors: Mariana H Remião; Natalia V Segatto; Adriana Pohlmann; Silvia S Guterres; Fabiana K Seixas; Tiago Collares Journal: Front Pharmacol Date: 2018-01-11 Impact factor: 5.810